Novel N-substituted indole hydrazones as potential antiplatelet agents: synthesis, biological evaluations, and molecular docking studies
Background and purpose: Antiplatelet agents can diminish the chance of coronary heart diseases due to the prevention of unusual clotting in the arteries by inhibiting platelet aggregation and avoiding the formation of a blood clot. This mechanism can help to prevent ischemic stroke likewise. To impr...
Saved in:
Main Authors: | Navid Tavili, Shaya Mokhtari, Hafezeh Salehabadi, Marjan Esfahanizadeh, Shohreh Mohebbi |
---|---|
Format: | article |
Language: | EN |
Published: |
Wolters Kluwer Medknow Publications
2022
|
Subjects: | |
Online Access: | https://doaj.org/article/4ac94315828a4821975b569668718b3e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Strategic approach to developing a self-microemulsifying drug delivery system to enhance antiplatelet activity and bioavailability of ticagrelor
by: Na YG, et al.
Published: (2019) -
ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)
by: E. Y. Kitaeva, et al.
Published: (2017) -
INDOLE DERIVATIVES AS POTENTIAL ANTICANCER AGENTS: A REVIEW
by: Sachdeva,Harshita, et al.
Published: (2020) -
Response to antiplatelet therapy in patients undergoing invasive treatment due to acute coronary syndrome complicated by cardiogenic shock
by: Wiktor Kuliczkowski, et al.
Published: (2020) -
Early Surgery with Neuraxial Anaesthesia in Patients on Chronic Antiplatelet Therapy with a Proximal Femur Fracture: Multicentric Randomised Clinical Trial
by: Rafael Anaya, et al.
Published: (2021)